|
|
||||||||
APPETITE, OBESITY, DIGESTION, AND METABOLISM
1Department of Neuroscience, University of Cincinnati, Cincinnati; and 2Department of Psychiatry, 3Department of Internal Medicine, and 4Department of Pathology and Laboratory Medicine, Genome Research Institute, Cincinnati, Ohio
Submitted 18 January 2005 ; accepted in final form 27 April 2005
Oleoylethanolamide (OEA), a lipid synthesized in the intestine, reduces food intake and stimulates lipolysis through peroxisome proliferator-activated receptor-
. OEA also activates transient receptor potential vanilloid type 1 (TRPV1) in vitro. Because the anorexigenic effect of OEA is associated with delayed feeding onset and reduced locomotion, we examined whether intraperitoneal administration of OEA results in nonspecific behavioral effects that contribute to the anorexia in rats. Moreover, we determined whether circulating levels of other gut hormones are modulated by OEA and whether CCK is involved in OEA-induced anorexia. Our results indicate that OEA reduces food intake without causing a conditioned taste aversion or reducing sodium appetite. It also failed to induce a conditioned place aversion. However, OEA induced changes in posture and reduced spontaneous activity in the open field. This likely underlies the reduced heat expenditure and sodium consumption observed after OEA injection, which disappeared within 1 h. The effects of OEA on motor activity were similar to those of the TRPV1 agonist capsaicin and were also observed with the peroxisome proliferator-activated receptor-
agonist Wy-14643. Plasma levels of ghrelin, peptide YY, glucagon-like peptide 1, and apolipoprotein A-IV were not changed by OEA. Finally, antagonism of CCK-1 receptors did not affect OEA-induced anorexia. These results suggest that OEA suppresses feeding without causing visceral illness and that neither ghrelin, peptide YY, glucagon-like peptide 1, apolipoprotein A-IV, nor CCK plays a critical role in this effect. Despite that OEA-induced anorexia is unlikely to be due to impaired motor activity, our data raise a cautionary note in how specific behavioral and metabolic effects of OEA should be interpreted.
peroxisome proliferator-activated receptor-
; transient receptor potential vanilloid type 1; cholecystokinin; satiety; obesity
This article has been cited by other articles:
![]() |
J. Fu, J. Kim, F. Oveisi, G. Astarita, and D. Piomelli Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R45 - R50. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Astarita, B. C. Rourke, J. B. Andersen, J. Fu, J. H. Kim, A. F. Bennett, J. W. Hicks, and D. Piomelli Postprandial increase of oleoylethanolamide mobilization in small intestine of the Burmese python (Python molurus) Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1407 - R1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
Highlights from the Literature Physiology, August 1, 2005; 20(4): 213 - 217. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |